T The Defence Medical Services of the UK have been engaged on continuous deployed operations since the mid 1990s, in the Balkans, Iraq and Afghanistan. During this period, treatment of severe traumatic injury has taken great strides forward as clinical capability has increased to match the destructive power of the weaponry employed against British and allied forces. This improved capability has resulted in clinical outcomes that are often the envy of civilian trauma systems and which have received praise from independent reviewers. 1, 2 There are many explanations for these results, but a central theme is the unified team structure that exists within the military environment. This structure, based around strong clinical leadership, allows a team of often relatively untested individuals to come together and work effectively to an existing template of care that has been honed and refined by past experience. Examples of this can be seen in the initial resuscitation and evacuation of casualties in the pre-hospital environment, the application of the principles of damage control surgery and resuscitation in the emergency department and operating theatre, and the use of massive transfusion protocols. Further into the patient journey, the strategic aeromedical evacuation of critically ill casualties is performed by a highly trained and experienced cohort of clinicians and nurses. Underpinning all these aspects of care is the requirement to deploy intensive care assets into the operational environment.
Military medical roles and doctrine
In recent military operations, treatment levels have been divided into doctrinal roles of medical support. 
The role of deployed intensive care
The deployed intensive care unit (ICU) exists to support the clinical activities of the deployed hospital, or forward medical unit, by providing care for the cohort of sickest patients. The role of intensive care on deployed operations is similar to that encountered in civilian practice. However, the patient base is generally young and fit, and patients usually experience less organ failure in response to the same insult than an average, often older, patient in a civilian setting. Treatment is often focused on ongoing aggressive resuscitation from traumatic injury, although patients held within the deployed ICU for longer periods often go on to exhibit a range of medium-to late-term sequelae, including infection and weaning failure, that are more common in civilian environments. All intensivists are familiar with pressure on resources but this can be particularly apparent in the deployed setting where a relatively small number of intensive care beds can rapidly be overwhelmed by a large numbers of casualties. There is therefore an imperative to rapidly evacuate patients to Role 4 facilities once any immediately life-threatening conditions have been stabilised. However, the nature of deployed operations and the international law of armed conflict dictate that deployed medical facilities will receive enemy combatants and local national civilians, including children, in addition to their own and allied military personal. Often there is no easy repatriation mechanism for these patients and they will need to be managed within the deployed hospital for extended periods. Managing these patients in a relatively austere setting provides the main challenge for the deployed military intensivist.
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Deployed intensive care environments
At the time of writing, the Defence Medical Service is looking towards the end of combat operations in Afghanistan and into the future. It is a timely reminder that although recent years have seen a single theatre of operations and the concept of deployed intensive care, there have historically been many diverse environments where critically ill patients have been managed during military operations.
The mature Role 3 facility
This type of unit would be very familiar to a civilian intensivist. It is usually contained within a hard standing facility, is well lit and temperature-controlled. Bed spaces are large and equipped with modern electronic beds. There are usually adequate supplies of high-pressure oxygen, although cylinders rather than pipelines from a remote source will deliver this. Electricity generation is reliable and capable of delivering an uninterrupted supply under most circumstances. There are adequate areas for administration and staff downtime. Resupply is not normally a problem, with an air bridge delivering timely resupply of consumables and equipment. Strategic aeromedical evacuation is usually conducted from a co-located airhead, reducing the requirement for a secondary transfer. Examples of this type of facility include the latter build intensive care areas within the Role 3 Hospital at the Contingency Operating Base, Basra, Iraq (four beds) and the Role 3 Hospital at Camp Bastion, Afghanistan (16 beds). (Figure 1 ).
Primary Casualty Receiving Facility (PCRF)
The PCRF is housed within RFA Argus, a large multi-role vessel. Within this ship is a modular hospital, which contains a ten-bed intensive care facility (Figures 2 and 3) .
Many of the above comments relating to mature Role 3 settings also apply to this facility, although onward strategic aeromedical evacuation will necessarily be conducted from a remote airhead. The PCRF is designed to provide a secure Role 3 facility, which can be used in the initial stages of a conflict that involves a littoral component to the battle space.
Immature Role 3 Field Hospital
A newly deployed hospital, or a temporary unit deployed in the forward areas of the battle space will usually be housed in tented accommodation and the physical infrastructure will necessarily be relatively austere. There will be less physical space than in a hard standing facility and this may impact on some of the interventions that can be delivered. The working environment will be harsher and supply of essentials such as lighting, temperature control and medical gases will be difficult to guarantee. The impact of the environment will be much more pronounced and this may produce effects on staff and service delivery. Despite this the range of clinical and support services available are not dissimilar from a more mature deployed setting. There will be a laboratory service capable of supplying blood products and supporting a massive transfusion protocol. Near-patient testing in the form of ROTEM and iStat will usually be available. CT scanning facilities will be available in more established facilities but not necessarily during the initial, expeditionary phase.
Forward medical treatment (Role 2 and Role 2 Afloat)
Smaller facilities will often be used to support more mobile operations or where there is a very long chain of evacuation back to a larger facility. They can be land-based, and may be deliverable entirely from the air at short notice, or maritime. In the latter case a small intensive care facility can be placed on a variety of existing warships or auxiliary vessels. These facilities have the capacity to hold ventilated patients for some time prior to evacuation to Role 3 or 4.
However, they lack many of the services available at larger facilities. In addition to lack of imaging (mobile X-ray and ultrasound rather than CT), and reduced pathology services (limited blood tests and transfusion services, without platelets or cryoprecipitate) the equipment is also more basic. In the lighter Role 2 facilities, the intensive care ventilator is no more than a simple transport ventilator with an external PEEP valve. The intensive care beds are lightweight frames with issues for pressure area care. Monitoring is, however, similar, and the majority of drugs required for intensive care are available.
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Critical Care Air Support Teams (CCAST)
Evacuation of critically ill patients to Role 4 facilities is undertaken by specialist teams of clinicians and nurses from the Royal Air Forces Critical Care Air Support Teams. These teams are consultant-led and can continue virtually all intensive care interventions throughout the transfer period, thus providing an intensive care air bridge between deployed and home nation facilities. Teams are on standby 24 hours a day, and the mean time from hospital admission to patient evacuation during current operations in Afghanistan is less than 18 hours.
Military intensive care personnel
Historically intensive care provision within the DMS has been very closely tied to the anaesthetic service. This practice also reflects the way intensive care has been delivered in the UK until relatively recently. The nature of clinicians deployed to cover intensive care services within the DMS has, however, evolved in tandem with changes in the wider intensive care community. There is a small but growing cadre of consultants within the DMS who are on the specialist register for intensive care medicine (ICM) and whose job plans reflect a substantial or near full-time commitment to ICM. The numbers of these individuals is set to increase sharply due to changes in ICM training in the UK implemented over the last ten years.
Although there are good reasons why plurality of specialism within intensive care is beneficial for patient care, this is less true in a military context. The nature of the workload and case-mix in a deployed military ICU is very heavily skewed towards surgical patients, and the main issues tend to revolve around weaning and analgesia in this patient group. There is also an emphasis on preparation for transfer of critically ill patients. The group of hospital specialists with the most exposure to and knowledge of these issues are anaesthetists, and the vast majority of military intensivists are also anaesthetic specialists. The delivery of intensive care on deployed operations is exclusively provided by consultants.
Intensive care nursing staff form one of the largest cadres of nurses within the DMS. They are drawn from all three services and when not on deployed operations, work within ICUs across the NHS.
Deployed clinical capabilities
Deployed ICUs have capabilities that are broadly comparable with the civilian environment. There are however some important differences.
Targeted resuscitation
An area in which military intensive care practice differs from that in a typical civilian unit is the impact of consultantdelivered, targeted resuscitation in the immediate post-injury period. The use of point-of-care coagulation monitoring with thromboelastography (ROTEM) has become a core component of this approach and ensures very rapid delivery of appropriate blood products to patients with acute trauma and shock coagulopathy. We have also recently introduced a method of volume status assessment using focused echocardiography, which is fast becoming a standard of care in the immediate postoperative phase of resuscitation. All interventions are delivered by a consultant intensivist who is immediately available within the ICU around the clock.
Monitoring intra-cranial pressure (ICP)
Currently, ICP can only be measured if a ventricular catheter has been inserted at the neurosurgical facility. Insertion of intracranial pressure bolts, while feasible, has not been adopted due to problems with safety of the monitors and reliability of the readings generated during air transfer, and subsequent compatibility with monitors at the Role 4 hospital. It is recognised that this capability is important and necessary, and work is ongoing to find a solution. For the present, a lower threshold for repeat CT scanning and the assumption of a substantially raised ICP are the cornerstones of management.
Renal replacement therapy (RRT)
The development of acute renal failure (ARF) requiring extracorporeal replacement therapy is a common feature of critical illness. However, it is much less prevalent in the military intensive care environment where the patient population has fewer risk factors for renal failure. The onset of ARF is often a marker of increased illness severity with associated worse outcome. In a patient who cannot be evacuated to a Role 4 facility this can represent an ominous sign. The core purpose of the deployed ICU is to provide a bridge to onward transfer and provision of RRT does not easily fit into this model. Additionally the physical space and consumable resources used during RRT are not practicable in all but the most mature deployed environments. Provision of RRT to patients who cannot be evacuated is a difficult ethical decision. It may be appropriate if there is a clearly reversible cause for the renal failure. However, patients with multiple failing organs who develop the requirement for RRT will have a greatly increased mortality and a prolonged length of intensive care dependency even in the event of survival. All of these factors taken together preclude the routine provision of RRT in deployed intensive care. There may be circumstances where RRT may be available in the operational environment, for example from host nation or allied forces. If these exist, they can be sought out at the discretion of the treating intensivist.
Advanced respiratory support
There is a small cohort of injured patients who will develop severe lung injury and become difficult to oxygenate or ventilate. The new Vela ventilator offers a considerable increase in capability, including an airway pressure release ventilation (APRV) mode, which enables an open-lung ventilation strategy to be used. However, there is currently no facility to provide high-frequency oscillatory ventilation (HFOV) or
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extracorporeal oxygenation/CO 2 removal in the deployed environment. Introducing such capability would necessarily involve training and equipping those responsible for providing strategic aeromedical evacuation. There are currently no plans for the UK to develop this capability, although the United States military does provide such a service that has been used, thanks to the coalition collaborative effort during the Afghanistan conflict.
Nutrition
As the emphasis of the deployed unit is on short-term support there is no provision to provide total parenteral nutrition (TPN). This would be difficult to deliver in most operational settings and it is rare to encounter patients who cannot be enterally fed by day seven of their stay in the deployed ICU. Although there are no dieticians attached to the deployed hospital a reach-back service provides advice from the UK.
Tracheostomy
Most tracheostomies created in the deployed environment are indicated for actual or threatened airway obstruction, secondary to facial trauma or burns. There is facility to perform tracheostomy percutaneously if this is required for weaning.
Bronchoscopy
More mature intensive care areas usually have provision for bronchoscopy, but this is not currently a core capability because of sterilisation and maintenance issues in less mature settings. Single-use devices may have a role in the future.
Pathology support
Mature Role 3 facilities will normally possess a wide range of microbiological laboratory services. However, the facility to perform specialist assays may be limited. A forward or immature facility will lack many of these services. Remote support from specialists (eg microbiologists) at Role 4 is available where communications exist.
Ethical decision making in deployed intensive care
Ethical issues do not usually complicate the provision of intensive care support to UK or allied service personnel. Any questions about the benefit of treatments and eventual outcome for an individual service patient are usually best addressed at Role 4 following strategic evacuation. However, intensive care on deployed operations almost invariably involves treating local national personnel who may lack an effective route of onward evacuation. It is these patients who will frequently pose ethical challenges. The deployed intensivist has a dual obligation under these circumstances. The primary and overriding duty is provision of care to the patient before them, in accordance with best clinical practice, while at all times conforming to the standards and expectations of their national professional bodies. However, there is also a duty to the wider deployed organisation, including other service personnel and operational commanders, who will view the intensive care facility as a military resource to be used in support of ongoing operations.
Balancing these dual obligations can be a challenge but difficult decisions will always be a part of the role of an intensivist, whether civilian or military. In recent years, the military have used a Deployed Medical Director, a senior clinician in overall medical charge of the deployed hospital, to lead ethical debate and, ultimately, to make the final decision regarding patient management in difficult cases. It is important to emphasise that the core principals of good medical practice are applicable to all doctors working in a deployed setting and that the same standards of care, including priority to treatment, consent and confidentiality, apply to all patients in a field hospital ICU, regardless of their background, nationality or potential status as enemy combatants. 3
Conclusion
Military and civilian intensive care has much in common. This includes both the equipment used and the ethical challenges that may arise. However, there are differences that must be appreciated by military intensivists to ensure that they understand the limitations of care which may be imposed due to both situational and logistical constraints. These are even more pronounced in the Role 2 environment, where military intensive care may be placed more frequently as the UK military looks ahead toward future operations in less mature settings.
